Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Identifying Actionability as a Key Factor for the Adoption of ‘Intelligent’ Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach
10
Zitationen
4
Autoren
2021
Jahr
Abstract
We highlight the fact that beyond providing analytics and useful statistics to the end user, 'actionability' has emerged as the operational priority identified through the whole process. Furthermore, we focus on the needs for valid, reproducible, explainable and human-interpretable results, stressing the need to emphasize on usability.
Ähnliche Arbeiten
BIOEDIT: A USER-FRIENDLY BIOLOGICAL SEQUENCE ALIGNMENT EDITOR AND ANALYSIS PROGRAM FOR WINDOWS 95/98/ NT
1999 · 38.713 Zit.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
2017 · 5.757 Zit.
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 · 4.552 Zit.
The price of innovation: new estimates of drug development costs
2003 · 4.278 Zit.
A rapid method for the isolation of functional thymus‐derived murine lymphocytes
1973 · 4.166 Zit.